Menu
Procalcitonin is a small peptide biomarker often present in the blood, as a patient experiences bacterial sepsis.
Response Biomedical offers a whole blood quantitative immunoassay Procalcitonin test, with our proprietary RAMP technology which assess the levels of PCT in patients around the world in ~15 minutes. Read more about how this product will help with the challenges labs and physicians face for sepsis patients, finding the right test for your needs.
Response Biomedical offers a whole blood quantitative immunoassay Procalcitonin test, with our proprietary RAMP technology which assess the levels of PCT in patients around the world in ~15 minutes. Read more about how this product will help with the challenges labs and physicians face for sepsis patients, finding the right test for your needs.
The Challenge
WHEN EARLY RECOGNITION OF SEPSIS IS KEY
- Sepsis is a global health crisis with more than 30 million cases annually worldwide
- Early detection and treatment of sepsis has been proven to improve patient outcomes and reduce healthcare costs
- One-third of ICU patients with sepsis die before leaving the hospital
- Sepsis is one of the most expensive conditions to treat, with costs exceeding $20 billion USD annually in the US alone
The Solution
TEST PRINCIPLES
RAMP PROCALCITONIN Test
- Procalcitonin(PCT) is a sensitive biomarker elevated in the blood of patients suffering from sepsis. Physicians use PCT to distinguish bacterial sepsis from other causes of similar symptoms
- RAMP Procalcitonin provides quantitative results in ~15 minutes directly from a small blood sample.
- When speed, precision and accuracy are critical, the RAMP Procalcitonin test provides clinicians the results they need for making informed patient management decisions.
Additional Information
data
24 Hour Technical Support Available for all RAMP Customers
Contact Our Specialists
Start Testing Today
